Year archive

Spexis AG — 2017 filings

All 10 regulatory filings released by Spexis AG (SPEX) in 2017, sourced directly from the official regulator.

10 Filings

2017 Period

2017 filings (10)

Filing	Released	Lang
Polyphor AG: Polyphor launches the development of an inhaled formulation of its antibiotic Murepavadin and joins a European consortium of leading hospitals and research institutions Regulatory Filings	2017-10-12	English
Polyphor AG: Polyphor achieves ahead of schedule first milestone from Wellcome Trust for the development of novel antibiotics against Gram-negative multidrug - resistant pathogens Earnings Release FY 2017	2017-07-18	English
Polyphor AG: Polyphor contributes to the progress in understanding Neutrophil Elastase Science Regulatory Filings	2017-07-10	English
Polyphor AG: Kalina Scott appointed new CFO of Polyphor Board/Management Information	2017-05-23	English
Polyphor AG: Polyphor announces successful end of phase II meeting with FDA for Murepavadin in nosocomial pneumonia Regulatory Filings	2017-05-19	English
Polyphor AG: Outer-Membrane Protein Targeting Antibiotics (OMPTAs) - New hope against antibiotic resistance Regulatory Filings	2017-04-24	English
Polyphor announces two oral and six poster presentations plus a press conference at the 27th ECCMID Congress, Vienna Regulatory Filings	2017-04-20	English
Polyphor AG: Polyphor announces closing of CHF 40 million private financing round Share Issue/Capital Change	2017-04-12	English
Polyphor AG: Debra Barker Appointed New CMDO of Polyphor Board/Management Information	2017-03-06	English
Polyphor AG: Polyphor Receives CHF 2.3 Million Award from Wellcome Trust to Accelerate the Development of a Novel Antibiotic Drug Class Regulatory Filings	2017-02-09	English

Filings by year

2024 20 filings
2023 38 filings
2022 36 filings
2021 20 filings
2020 20 filings
2019 21 filings
2018 19 filings
2017 10 filings
2016 6 filings
2015 4 filings